Seizure control in tumor-associated epilepsy secondary to BRAF inhibition
Por:
Pérez-Somarriba M, Santa-María López V, Cruz-Martínez O, Muchart-Lopez J, Gene-Olaciregui N, Hinojosa J, González V and Morales-La Madrid A
Publicada:
1 abr 2023
Ahead of Print:
1 nov 2022
Resumen:
Filiaciones:
Pérez-Somarriba M:
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain
Santa-María López V:
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain
Cruz-Martínez O:
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain
Muchart-Lopez J:
Department of Radiology, Hospital Sant Joan de Déu, Barcelona, Spain
Gene-Olaciregui N:
Department of Developmental Tumor Biology Laboratory, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain
Hinojosa J:
Department of Pediatric Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain
González V:
Department of Pediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain
Morales-La Madrid A:
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain
|